| Compound Information | SONAR Target prediction | | Name: | CHOLESTEROL | | Unique Identifier: | SPE01500847 | | MolClass: | Checkout models in ver1.5 and ver1.0 | | Molecular Formula: | | | Molecular Weight: | 340.288 g/mol | | X log p: | 3.038 (online calculus) | | Lipinksi Failures | 0 | | TPSA | 0 | | Hydrogen Bond Donor Count: | 0 | | Hydrogen Bond Acceptors Count: | 1 | | Rotatable Bond Count: | 5 | | Canonical Smiles: | CC(C)CCCC(C)C1CCC2C3CC=C4CC(O)CCC4(C)C3CCC12C | | Class: | sterol | | Source: | common animal sterol | | Generic_name: | CHOLESTEROL | | Chemical_iupac_name: | CHOLESTEROL | | Drug_type: | Experimental | | Kegg_compound_id: | C00187 | | Drugbank_id: | EXPT00945 | | Logp: | 7.445 | | Cas_registry_number: | 57-88-5 | | Drug_category: | Nuclear Receptor Ror-Alpha inhibitor | | Organisms_affected: | -1 |
| Species: |
4932 |
| Condition: |
HOG1 |
| Replicates: |
2 |
| Raw OD Value: r im |
0.7570±0.0424264 |
| Normalized OD Score: sc h |
1.0401±0.0303323 |
| Z-Score: |
1.0352±0.652348 |
| p-Value: |
0.350262 |
| Z-Factor: |
-2.55789 |
| Fitness Defect: |
1.0491 |
| Bioactivity Statement: |
Nonactive |
| Experimental Conditions | | | Library: | Spectrum_ED | | Plate Number and Position: | 2|F3 | | Drug Concentration: | 50.00 nM | | OD Absorbance: | 595 nm | | Robot Temperature: | 30.00 Celcius | | Date: | 2010-08-10 YYYY-MM-DD | | Plate CH Control (+): | 0.09325±0.00621 | | Plate DMSO Control (-): | 0.85275±0.01400 | | Plate Z-Factor: | 0.9182 |
|  png
ps
pdf |
| 556564 |
4a-methyl-2,3,4,5,6,7-hexahydro-1H-naphthalen-2-ol |
| 556731 |
1,2,3,3a,4,6a-hexahydropentalen-1-ol |
| 562328 |
n/a |
| 572104 |
17-(5-hydroxy-5-methyl-hexan-2-yl)-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopent
a[a]phenanthren-3-ol |
| 573923 |
2-(1-cyclopent-2-enyl)norbornan-2-ol |
| 579641 |
2-(2-ethyl-1,3-dimethyl-1-cyclopent-2-enyl)propan-2-ol |
| internal high similarity DBLink | Rows returned: 8 | 1 2 Next >> |
| active | Cluster 17506 | Additional Members: 20 | Rows returned: 4 | |
|
